Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation
N/A
N/A
N/A
N/A
N/A
Open (Enrolling)
Female
Breast Cancer
Female
Breast Cancer
Trial Information
Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation
Inclusion Criteria:
- core biopsy with diagnosis of breast cancer
- start of neo-adjuvant chemotherapy
Exclusion Criteria:
- magnetic resonance imaging incompatibility
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Response to chemotherapy
Outcome Description:
outcome is the results of pathology after chemotherapy and surgery. Data will be collected for a period of 1 year.
Outcome Time Frame:
1 year
Safety Issue:
No
Principal Investigator
Chantal Van Ongeval, MD, Phd
Investigator Role:
Principal Investigator
Investigator Affiliation:
Universitaire Ziekenhuizen Leuven
Authority:
Belgium: Institutional Review Board
Study ID:
B322201213618
NCT ID:
NCT01684735
Start Date:
March 2012
Completion Date:
June 2013
Related Keywords:
- Breast Cancer
- diffusion-weighted magnetic resonance imaging
- Body Weight
- Breast Neoplasms
Name | Location |
|---|
